Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart

被引:8
|
作者
Gong, Feng-Ming [1 ]
Peng, Xing-Chen [1 ]
Tan, Ben-Xu [1 ]
Ge, Jun [1 ]
Chen, Xi [1 ]
Chen, Ye [1 ]
Xu, Feng [1 ]
Bi, Feng [1 ]
Hou, Jian-Mei [1 ]
Liu, Ji-Yan [1 ]
机构
[1] Sichuan Univ, Dept Med Oncol, Ctr Canc, W China Hosp,W China Med Sch,State Key Lab Biothe, Chengdu 610064, Sichuan Prov, Peoples R China
基金
中国国家自然科学基金;
关键词
colorectal carcinoma; drug resistance; irinotecan; two-dimensional gel electrophoresis; THIOREDOXIN REDUCTASE; GLUTATHIONE-REDUCTASE; CANCER STATISTICS; MECHANISM; COFILIN; THERAPY; SELENOPROTEIN; ACTIVATION;
D O I
10.1097/CAD.0b013e3283408596
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we used two-dimensional gel electrophoresis and MALDI-Q-TOF-MS/MS analysis to examine the global protein expression of a pair of colorectal carcinoma cell lines, SW620 and irinotecan-resistant SW620. Of the 30 spots identified as differentially expressed proteins (+/- over twofold, P < 0.05) between the two cell lines, 26 spots (corresponding to 26 unique proteins) were positively identified by MALDI-Q-TOF-MS/MS analysis. These proteins could be grouped into main classes including metabolism (15.38%), cell SSproliferation/differentiation (11.53%), molecular chaperone (11.53%), mRNA splicing (11.53%), and so on. The proteins, which might be involved in the development of tumor drug resistance, such as a-enolase, cofilin, and thioredoxin-dependent peroxide 1, have been validated by western blot analysis and have been discussed. The proteins identified in this study may be useful in showing the mechanisms underlying irinotecan resistance. Anti-Cancer Drugs 22:500-506 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 50 条
  • [1] Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10
    Le Moguen, Karen
    Lincet, Hubert
    Deslandes, Edwige
    Hubert-Roux, Marie
    Lange, Catherine
    Poulain, Laurent
    Gauduchon, Pascal
    Baudin, Bruno
    PROTEOMICS, 2006, 6 (19) : 5183 - 5192
  • [2] Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
    Qiang-ling Sun
    Hui-fang Sha
    Xiao-hua Yang
    Guo-liang Bao
    Jing Lu
    Yin-yin Xie
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 521 - 532
  • [3] Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
    Sun, Qiang-ling
    Sha, Hui-fang
    Yang, Xiao-hua
    Bao, Guo-liang
    Lu, Jing
    Xie, Yin-yin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (03) : 521 - 532
  • [4] Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: Predictors of chemoresistant disease
    Kim, S.
    Kim, S.
    Nam, E.
    Lee, D.
    Jang, S.
    Jung, Y.
    Kim, J.
    Kim, J.
    Kim, Y.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S118 - S119
  • [5] Comparative Proteomic Analysis of Advanced Serous Epithelial Ovarian Carcinoma: Possible Predictors of Chemoresistant Disease
    Kim, Sang Wun
    Kim, Sunghoon
    Nam, Eun Ji
    Jeong, Yong Wook
    Lee, San Hui
    Paek, Ji Heum
    Kim, Jae Hoon
    Kim, Jae Wook
    Kim, Young Tae
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2011, 15 (05) : 281 - 292
  • [6] Proteomic analysis of a metastatic versus non-metastatic human colorectal carcinoma cell line
    Zhang, Y. T.
    Geng, Y. P.
    Lai, B. C.
    Si, L. S.
    Wang, Y. L.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S61 - S61
  • [7] Proteomic analysis of a nasopharyngeal carcinoma cell line and a nasopharyngeal epithelial cell line
    Huang, Pei-Yu
    Zeng, Ting-Ting
    Li, Meng-Qing
    Ban, Xiaojiao
    Zhu, Ying-Hui
    Zhang, Bao-Zhu
    Mai, Hai-Qiang
    Zhang, Li
    Guan, Xin-Yuan
    Li, Yan
    TUMORI JOURNAL, 2015, 101 (06): : 676 - 683
  • [8] Comparative proteomic analysis of esophageal squamous cell carcinoma
    Qi, YJ
    Chiu, JF
    Wang, LD
    Kwong, DLW
    He, QY
    PROTEOMICS, 2005, 5 (11) : 2960 - 2971
  • [9] A cell line from large cell neuroendocrine carcinoma (LCNEC) of the lung and its genetic and proteomic analysis
    Nomura, Masaharu
    Nishimura, Toshihide
    Ohira, Tatsuo
    Tojo, Hiromasa
    Nonomura, Shinobu
    Endo, Hiroko
    Bando, Yasuhiko
    Fujii, Kiyonaga
    Ikeda, Norihiko
    Gazdar, Adi
    CANCER RESEARCH, 2009, 69
  • [10] Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart
    Rosati, A
    Decorti, G
    Klugmann, FB
    Candussio, L
    Granzotto, M
    Melato, M
    Giraldi, T
    ANTICANCER RESEARCH, 2000, 20 (5B) : 3403 - 3410